WO2003034055A1 - Procede de mesure de concentration et dispositif de mesure de concentration - Google Patents
Procede de mesure de concentration et dispositif de mesure de concentration Download PDFInfo
- Publication number
- WO2003034055A1 WO2003034055A1 PCT/JP2002/010505 JP0210505W WO03034055A1 WO 2003034055 A1 WO2003034055 A1 WO 2003034055A1 JP 0210505 W JP0210505 W JP 0210505W WO 03034055 A1 WO03034055 A1 WO 03034055A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- concentration
- physical quantity
- liquid junction
- measuring
- detection
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 239000007788 liquid Substances 0.000 claims abstract description 118
- 238000001514 detection method Methods 0.000 claims abstract description 81
- 210000004369 blood Anatomy 0.000 claims description 62
- 239000008280 blood Substances 0.000 claims description 62
- 238000005259 measurement Methods 0.000 claims description 61
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 23
- 239000008103 glucose Substances 0.000 claims description 23
- 238000012937 correction Methods 0.000 claims description 18
- 239000000523 sample Substances 0.000 claims description 18
- 239000012488 sample solution Substances 0.000 claims description 14
- 238000012545 processing Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 210000000601 blood cell Anatomy 0.000 claims description 8
- 238000011144 upstream manufacturing Methods 0.000 claims description 4
- 238000000691 measurement method Methods 0.000 claims 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 230000004044 response Effects 0.000 description 64
- 238000005534 hematocrit Methods 0.000 description 19
- 239000000758 substrate Substances 0.000 description 14
- 125000006850 spacer group Chemical group 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000007791 liquid phase Substances 0.000 description 7
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000001268 chyle Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000006479 redox reaction Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
Definitions
- the present invention relates to a technique for measuring the concentration of a specific component (for example, glucose or cholesterol) in a sample solution (for example, blood or urine).
- a specific component for example, glucose or cholesterol
- FIGS. 11 and 12 of the present application there are biosensors shown in FIGS. 11 and 12 of the present application.
- the biosensor 9 shown in these figures has a substrate 92, a spacer 93, a cover 94, and a cabillary 95 constituted by these components.
- a working electrode 90 and a counter electrode 91 are formed on the substrate 92.
- Portions 90 a and 91 a of the working electrode 90 and the counter electrode 91 located in the capillaries 95 are connected by a reagent part 96.
- the reagent section 96 contains, for example, an oxidoreductase and an electron mediator.
- the cover 94 has an exhaust port 94 a, and is stacked on the substrate 92 via a spacer 93.
- the inside of the capillary 95 communicates with the outside via an open end 93a of the slit 93A and an air opening 94a.
- concentration measuring device In actual concentration measurement, for example, blood is supplied to the cabillary 95 with the biosensor 9 attached to the concentration measuring device. This blood proceeds through the capillary 95 to the exhaust port 94a by capillary action, and in the process, the reagent Dissolve part 96, and construct a liquid phase reaction system in the capillaries 95.
- the concentration measuring device the response current value obtained by using the working electrode 90 and the counter electrode 91 (or the response ⁇ value obtained by converting the response current value) is stored in the capillary 95. The power to which the sample liquid has been supplied is determined. More specifically, if the response current value (or the response m ⁇ i force is equal to or greater than a preset threshold value, it is determined that blood has been supplied.
- oxidoreductase catalyst By the action, for example, gnorecose in blood is oxidized and the electron mediator is reduced, and when applied to the liquid phase reaction system, the electron mediator is oxidized (releases electrons).
- the electrons emitted by the electron mediator are supplied to the working electrode 90.
- the amount of electrons supplied to the working electrode 90 is measured as an oxidation current, and based on the oxidation current value,
- the response current value reflects the amount of electrons supplied to the working electrode 90, and the amount of electrons supplied to the working electrode 90 is the amount of oxidized glucose, ie, glucose. Reflects the concentration.
- the blood contains blood cell components such as red blood cells, and the amount of this blood cell component affects the measured response current value, while the amount of blood cell component in the blood is affected.
- Hematocrit value varies among individuals, and the hematocrit value varies depending on the physical condition, etc., even for the same person. In some cases, proper measurement may not be possible due to the effect of hematocrit, not only for hematocrit, but also for chyle in blood chyle MS and hemolysis in blood cell components. l may affect the measured response current.
- the hematocrit value of blood is measured in advance, and the blood sugar level is calculated in consideration of the hematocrit value.
- a method in which the hematocrit value of blood is measured in advance, and the blood sugar level is calculated in consideration of the hematocrit value See Japanese Patent Application Publication No. 1941108).
- it is necessary to input a hematocrit value to the blood glucose measuring device so that the measuring operation becomes troublesome.
- the frequency of using the blood glucose measurement device is high ⁇
- inputting the hematocrit value is troublesome. It is.
- it is necessary to measure the hematocrit value of the measurer using a device different from the blood glucose measurement device and this work also adds to the inconvenience.
- An object of the present invention is to enable appropriate concentration measurement in consideration of the influence of coexisting components in a sample solution without imposing a burden on a user.
- the concentration measuring method according to the first aspect of the present invention is a method for measuring the concentration of a specific component in a sample liquid using a measuring tool, wherein a sample liquid is moved as the measuring tool. And first, second, and third sensing elements used to measure an electrical physical quantity, and the first, second, and third sensing elements are arranged in this order.
- a measuring step of measuring an electrical physical quantity for calculation using the It is characterized in that Motodzure electrically physical quantity, Te including an arithmetic scan Tetsupu for calculating the concentration of the specific component.
- the concentration measuring method according to the present invention is a method for calculating the required time from when a liquid junction is detected in the first detection step to when a liquid junction is detected in the second detection step.
- the method further includes a step. In this case, in the calculating step, it is preferable to calculate the concentration of the specific component in consideration of the required time.
- the calculating step includes, for example, calculating the electrical physical quantity for the calculation or the calculated value according to a correction value for correcting a calculated electrical physical quantity or a calculated value obtained based on the calculated electrical physical quantity. This includes the data processing operation to be corrected. .
- the calculation value includes, for example, a value obtained by converting a response current value in a case where an electrical physical quantity is measured as a response current value into a low value, a calculated value of a density obtained by calculation without performing correction, and the like.
- the correction value indicates the relationship between the required time and the correction value. It is preferable to use the one calculated based on the corresponding data.
- the electrical physical quantity is measured using all of the first to third detection elements, and based on the time course of the electrical physical quantity, the second physical element is measured. It is preferable to determine whether there is a liquid junction between the third sensing element and the third sensing element.
- an electrical physical quantity is measured at a plurality of measurement points set for each specific time, and a current value change amount per unit time is calculated for each measurement point.
- a predetermined threshold value it is determined that a liquid junction has occurred between the second and third detection elements.
- a difference between an electrical physical quantity measured at a certain measurement point and an electrical physical quantity measured at a measurement point set immediately before the measurement point is calculated, and the difference is set in advance. Even if it is larger than the threshold value, it may be determined that a liquid junction has occurred between the second and third detection elements.
- the measuring tool it is preferable to use a measuring tool whose surface area of the third sensing element is larger than that of the first sensing element.
- an electrical physical quantity measured after a lapse of a predetermined time after it is determined that a liquid junction has occurred between the second and third detection elements in the second detection step and a second measurement step. It is preferable to calculate the concentration of the specific component based on a difference from an electrical physical quantity measured when it is determined that a liquid junction has occurred between the second and third detection elements.
- the sample liquid for example, a liquid containing a coexisting substance that causes an error in measuring the concentration of a specific component is used.
- the required time is grasped as reflecting the influence of the above coexisting substances.
- the sample liquid when the sample liquid is blood, a blood cell component as a coexisting substance that causes a measurement error can be mentioned, and as a specific component, gnorecosse can be mentioned.
- the sample liquid include urine and saliva, and other samples such as saliva, and of course, samples other than raw histological samples can also be used.
- an apparatus for measuring the concentration of a specific component in a sample liquid using a measuring tool wherein the sample liquid is moved as the measuring tool.
- detecting means for detecting whether or not a liquid junction has occurred between the first and second detecting elements and between the second and third detecting elements; and the first or second detecting element.
- Electrical physical quantity measuring means for measuring an electrical physical quantity for calculation using at least two of the third detection elements; and e based on the electrical physical quantity for calculation.
- a calculating means for calculating the concentration of the specific component.
- the concentration measuring device of the present invention is configured to further include a ⁇ ⁇ applying means for applying between the at least two detection elements selected from the first to third detection elements.
- the electric physical quantity measuring means is configured to measure an electric physical quantity as a current value when ⁇ E is applied by, for example, the Iff applying means.
- the electrical physical quantity measuring means may be configured to measure a resistance value or the like as an electrical physical quantity.
- the calculating means calculates the time required from when a liquid junction between the first and second detection elements to the liquid junction between the second and third detection elements takes into account the above-mentioned required time. Then, it is preferable to calculate the concentration of the specific component.
- the electrical physical quantity measuring means is configured to measure the electrical physical quantity at, for example, a plurality of measurement points set at specific time intervals.
- the detecting means is configured to determine whether or not a liquid junction has occurred between the second and third detecting elements based on the time course of the electrical physical quantity.
- the detecting means calculates, for example, the amount of change in the current value per unit time at each measurement point, and if the amount of change in the current value is larger than a predetermined threshold, It is configured to determine that a liquid junction has occurred between the three detection elements.
- the detection means calculates a difference between the electrical physical quantity measured at a certain measurement point and the electrical physical quantity measured at the measurement point set immediately before the measurement point. May be calculated, and if the difference is larger than a preset threshold ⁇ , it is determined that a liquid junction has occurred between the second and third detection elements.
- the calculating means includes, for example, an electric physical quantity measured after a lapse of a predetermined time from the detection of a liquid junction between the second and third detecting elements, and a detecting means. It is configured to calculate the concentration of a specific component based on the measured value when a liquid junction between the second and third sensing elements is detected.
- FIG. 1 is for describing the first embodiment of the present invention, and is a schematic diagram showing a state where a biosensor is mounted on a concentration measuring device.
- FIG. 2 is an overall diagram of the biosensor shown in FIG.
- FIG. 3 is a view of ⁇ ⁇ ⁇ of the biosensor shown in FIG.
- FIGS. 4A to 4E are cross-sectional views corresponding to a cross-section taken along the line IV_IV in FIG. 2 for explaining the state of blood movement in the capillaries.
- FIG. 5 is a flowchart for explaining the concentration measurement processing operation.
- FIG. 6 is for explaining the second embodiment of the present invention, and is a schematic diagram showing a state where a biosensor is mounted on a concentration measuring device.
- Figure 7 shows the entire biosensor shown in Figure 6! It is a view.
- FIG. 8 is an exploded perspective view of the biosensor shown in FIG.
- FIG. 9 is a flowchart for explaining the concentration measurement processing operation.
- FIG. 10 is a flowchart for explaining the liquid junction detection processing in the concentration measurement processing operation.
- FIG. 11 is an exploded perspective view showing an example of a conventional bisensor.
- FIG. 12 is a cross-sectional view of the biosensor shown in FIG. BEST MODE FOR CARRYING OUT THE INVENTION
- the concentration measuring device 1 uses a biosensor 2 to This is for measuring the concentration of a specific component.
- Control unit 10 storage unit 11, switching unit 12, ff application unit 13, current value measurement unit 14, detection unit 15, calculation unit 16 And a display unit 17.
- the biosensor 2 has a substrate 3, first and second spacers 40 and 41, and a cover 5, and these constitute a cabin 6. .
- a working electrode 31 extending in the longitudinal direction of the substrate 3, and first and second counter electrodes 32 and 33 are formed. These electrodes 31 to 33 are arranged side by side in the lateral direction of the substrate 3, and both ends 31a to 33a and 31b to 33b are exposed such that the electrodes 31 to 33b are exposed. Covered by 3 4
- the working electrode 31 and the ends 31 a to 33 a of the first and second counter electrodes 32 and 33 are connected by a reagent part 35.
- the reagent section 35 is formed in a solid form containing, for example, an oxidoreductase and an electron transfer substance. The type of oxidoreductase or electron mediator is selected according to the type of the component to be measured. A ferricyanide rim is used as the transmitter.
- the cover 5 is laminated on the substrate 3 via the first and second spacers 40 and 41 and is laminated.
- the first and second spacers 40 and 41 have a constant thickness, cover a short direction of the substrate 3 in a row, and are arranged side by side in the longitudinal direction.
- the first and second spacers 40 and 41 have a height dimension inside the cavity 6. It defines the width and dimensions, and thus the internal shape of the cabinet 6. More specifically, the cavity 6 is formed as having an internal space extending in the lateral direction of the substrate 3, and the internal space communicates with the outside of the cavity 6 through the openings 60 and 61. It's been done.
- the sample liquid B moves the inside of the cavity 6 toward the opening 61 by capillary action. It moves, and finally, the interior of the cavity 6 is filled with the sample solution B as shown in FIG. 4E.
- the reagent part 35 is melted by the sample solution.
- a liquid phase reaction system is built inside the cavity 6.
- an oxidation-reduction reaction occurs, and a reaction product correlated with the amount of the component to be measured is obtained.
- the component to be measured is gnorecose, for example, the glucose is oxidized while the electron mediator is reduced.
- the reduced electron transfer material emits electrons by applying a force to the liquid phase reaction system via, for example, the working electrode 31 and at least one of the counter electrodes 32 and 33. The electrons emitted from the electron mediator are supplied to the working electrode 31.
- the control unit 10 shown in FIG. 1 is for controlling the operation of each unit 12 to 17.
- the storage unit 11 stores programs and data necessary for operating the units 12 to 17.
- the data stored in the storage unit 11 includes, for example, data relating to a sensor indicating the relationship between a response current value (or a ⁇ value obtained by converting the response current value) and a blood glucose level, and a calculation unit 16 And the correction value used in the density calculation in.
- the data on the correction straight line is, for example, the end of the working electrode 31 and the end of the second counter electrode 33 after the liquid junction between the ends 3 la and 32 a of the first counter electrode 32. It is stored as a tape stick or a mathematical expression indicating the relationship between the time required for liquid junction between 31a and 33a.
- the switching section 12 has first and second switching switches 12a and 12b. These switching switches 12 a and 12 b are individually turned on and off by the control unit 10. Therefore, by turning on and off the first and second switching switches 12 a and 12 b, the first counter electrode 32 or the second counter electrode 33 becomes the Sffi applying section 13 or the current value measuring section 1. It is possible to select whether or not to be conductively connected to 4.
- the 3 ⁇ 4 ⁇ applying unit 13 is for applying 3 ⁇ 41 between the working electrode 31 and the counter electrodes 32 and 33.
- the SEE applying unit 13 has a direct current such as a dry battery or a rechargeable battery.
- the current value measuring section 14 is for measuring a response current value when a voltage is applied between the working electrode 31 and at least one of the counter electrodes 32 and 33.
- the detection unit 15 is configured to determine whether a liquid junction has occurred between the working electrode 31 and the ends 31 a and 32 a of the first counter electrode 32 when the sample liquid is introduced into the cavity 6. In some cases, it is determined whether there is a liquid junction between the working electrode 3 1 and the end 3 1 a, 3 3 a of the second counter electrode 33. . It is for doing.
- the operation unit 16 calculates the liquid junction between the working electrode 31 and the ends 31 a and 32 a of the first counter electrode 32, and then sets the liquid crystal between the working electrode 31 and the ends 31 a and 33 a of the second counter electrode 33. Calculates the time required until the liquid leaks, calculates the correction value required for the concentration calculation from this required time, or calculates the correction value and the current value measured by the current value measurement unit 14. This is for calculating the concentration of a specific component in the sample solution.
- the display unit 17 is for displaying an error display in addition to the density calculation result in the calculation unit 16.
- the display unit 17 is composed of, for example, a liquid crystal display.
- Each of the control unit 10, the storage unit 11, the detection unit 15, and the calculation unit 16 can be configured with, for example, a CPU, a ROM, and a RAM, or a combination thereof. , 15, and 16 can also be configured by connecting a plurality of memories to one CPU.
- a method of measuring a blood glucose level using the concentration measuring device 1 and the biosensor 2 will be described with reference to a flowchart shown in FIG. 5 in addition to FIGS. 1 to 4.
- the first switching and the second switching switches 11a and 11b are assumed to be in an on state before the sensor 2 is attached.
- the biosensor 2 is attached to the concentration measuring device 1, and blood is introduced into the cabillary 6 via the opening 60 or 61 of the biosensor 2.
- ⁇ ⁇ 3E is applied between the working electrode 31 and the first counter electrode 32 of the biosensor 2 and between the working electrode 31 and the second counter electrode 33 by the voltage applying unit 13 (S 1 ).
- the current value measuring section 14 measures the response current value. (S2).
- the force between the working electrode 31 and the ends 31a and 32a of the first counter electrode 32 due to a liquid junction with the blood, or a certain point, is the end of the working electrode 31 and the second counter electrode 33. It is determined whether or not the force between the parts 31a and 33a is a liquid junction by blood (S3). This determination is made by the detection unit 15 monitoring the response current value measured by the current value measurement unit 14 and determining that the response current value is larger than a predetermined threshold. It is judged by force. When the response current value is larger than the threshold value, the detecting unit 15 determines that a liquid junction has occurred (S3: YES), for example, in a state as shown in FIG. 4C (S3: YES). For example, it is determined that the liquid junction is in the state shown in FIG. 4A or 4B and no liquid junction has occurred (S3: NO).
- S3 YES
- the direct current measurement of S2 and S Repeat the judgment of 3.
- the measurement of the response current value at this: ⁇ , S2 is, for example, 0.05. This is performed every 0.2 sec. However, if the liquid junction has not been detected after a predetermined number of determinations or a fixed time has elapsed, error processing may be performed. On the other hand, when a liquid junction is detected by the detection unit 15 (S3: YES), it is determined that the introduction of blood into the interior of the capillary 6 has been started, and the control unit 10 switches the first and second switching switches.
- One of the switching switches 12a and 12b is turned off (S4).
- S4 For example, when a liquid junction between the working electrode 31 and the ends 31a and 32a of the first counter electrode 32 is detected, it is determined that blood has been introduced into the interior of the capillary 6 through the opening 61, and 1 Turn off the switching switch 12a. As a result, 3 ⁇ 4 ⁇ application and current value measurement using the working electrode 31 and the second counter electrode 33 are enabled.
- a liquid junction between the working electrode 31 and the ends 31a and 33a of the second counter electrode 33 is detected, it is determined that blood has been introduced into the opening portion 60 and the inside of the cabillary 6, and (2) Turn off the switching switch 12b.
- the working electrode 31 and the first counter electrode 32 can be used to make it possible to apply the 3 ⁇ 4 ⁇ and measure the current value.
- the response current value is measured by the current value measurement unit 14 (S5), and the detection unit 15 detects the liquid junction again. Is performed (S6).
- S6 for example, when a liquid junction between the working electrode 31 and the ends 31a and 32a of the first counter electrode 32 is detected at S3, the working electrode 31 and the second counter electrode 32 are detected. It is detected whether or not a liquid junction has occurred between the ends 31a and 33a of the counter electrode 32.
- S3 when a liquid junction between the working electrode 31 and the end 31a, 33a of the second counter electrode 33 is detected, the end of the working electrode 31 and the end of the first counter electrode 32 are detected. It is detected whether or not the force between the parts 31a and 32a has a liquid junction. Is the force causing the liquid junction in S6?
- the determination of and the processing when no liquid junction is detected (S6: NO) are performed in the same manner as in S3.
- the arithmetic unit 16 detects a liquid junction in ° S3 (see FIG. 4C) and then detects a liquid junction in S6 (see FIG. 4D).
- the required time until the calculation is performed (S7), and a correction value is calculated from the required time (S8).
- the correction value is calculated based on a correspondence table indicating the relationship between the required time and the correction value stored in the storage unit 11.
- the correction value may be obtained as a value for correcting the response current value for calculation (or the king value obtained by converting this value), or the calculation value calculated using the detection It may be obtained as a correction.
- the detecting unit 15 determines whether or not a force has passed for a predetermined time since the liquid junction was detected in S6 (S9). This determination is repeated until the detection unit 15 determines that the predetermined time has elapsed (S9: YES). If the detection unit 15 determines ⁇ that the predetermined time has elapsed (S9: YES), the control unit # 10 turns on the switching switch 12a (12b) that was turned off in S4 (S9).
- the response current value for calculation is measured in the current value measuring section 14 (S11) However, in the current value measurement in S11, the switching switch 12a ( It is not necessary to turn on 12 b) Also, the response current is measured at a specific time after the liquid junction is detected at S6, and a certain period of time has elapsed since the liquid junction was detected at S6. The response current value after the lapse of time may be sampled, and the sampled response current value may be used as the response current value for the calculation. It may be performed after a certain time has passed since the liquid junction was detected.
- the arithmetic unit 16 calculates a blood glucose level based on the response current value and the correction value for calculation (S12).
- the calculation of the blood sugar level is performed, for example, by using a sensor indicating the relationship between the response current value (or a value obtained by converting the response current value) and the blood sugar level.
- the calculation result in S12 is displayed on the display unit 17 (S13).
- the sample solution contains blood cells in addition to the components to be measured.
- the component force S is included.
- the proportion of the blood cell component in the blood is expressed as a hematocrit value, and the magnitude of the hematotalit value affects the measured value.
- the blood having a higher hematocrit value has a higher viscosity, and the moving speed inside the capillary 6 decreases. Therefore, if the blood sugar level is calculated in consideration of the moving speed of blood inside the cavity 6, a more appropriate calculated value in consideration of the effect of the hematocrit value can be obtained.
- the concentration measuring device 1 can grasp the moving speed of blood. Therefore, it is not necessary to measure the hematocrit value of blood in advance or to input the hematocrit value to the concentration measuring device 1. This allows the measurer or user to measure the blood glucose level. The burden of measurement is reduced, and more appropriate measurement results can be obtained in consideration of the hematocrit value.
- 6 to 10 are for explaining the second embodiment of the present invention. In these figures, the same components as those described in the previous embodiment are denoted by the same reference numerals, and the same description is given below. Is omitted.
- the biosensor 2 ′ has a substrate 3 ′, a spacer 4 ′, and a cover 5 ′, and these constitute a calibrator 6 ′.
- a working electrode 31 'and a counter electrode 32' are formed on the upper surface 30 'of # 3'. Most of the working electrode 31 ′ extends in the longitudinal direction of the substrate 3 ′, and the force end 3 la ′ extends in the short direction of 3 ⁇ 43 ⁇ 43.
- the end 32A of the counter electrode 32 ' is provided with two extending portions 32Aa and 32Ab extending in the lateral direction.
- the second extension 32Ab has a larger surface area than the first extension 32Aa. Of course, the first and second extension portions 32Aa, 32Ab may be formed in the same size.
- the end 31a 'of the working electrode 31' is located between the first and second extensions 32Aa and 32 Ab.
- the first extension 32Aa, the end 3 la ', and the second extension 32 ab are arranged in the longitudinal direction of the substrate 3, and these portions 3 la', 32Aa, and 32 ab are connected.
- Reagent section 35 is provided.
- the spacer 4 ' is for defining the height inside the cavity 6'.
- the spacer 4 ' is provided with a slit 40' having an open end.
- the slit 40 ' defines the width of the inside of the capillary 6'.
- the opening at the tip of the slit 40 ' introduces the sample liquid into the interior of the capillary 6'.
- the cover 5 ' has an outlet 50'.
- the discharge port 50 ' is for discharging the gas inside the capillary 6' to the outside, and communicates with the inside of the capillary 6 '.
- the concentration measuring device 1 ′ shown in FIG. 6 is similar to the concentration measuring device 1 according to the first embodiment of the present invention shown in FIG. Department
- a current value measurement unit 14 a detection unit 15, a calculation unit 16 and a display unit 17 are provided.
- the switching unit is omitted in the concentration measuring device 1 'shown in FIG.
- the program and data stored in the storage unit 11 of the concentration measuring apparatus 1 ' is a part different from a thing to what concentration measuring apparatus 1 described above (see FIG. 1) .
- a blood sugar level measuring method using the concentration measuring device 1 'and the biosensor 2' will be described with reference to the flowcharts shown in Figs. 9 and 10 in addition to Figs.
- a biosensor 2 ' is attached to the concentration measuring device] /, and blood is introduced into the capillaries 6' through the supply port 60 'of the biosensor 2'.
- the concentration measuring device 1 ′ the voltage is applied between the working electrode 31 ′ of the biosensor 2 ′ and the counter electrode 32 ′ by the voltage applying unit 13 (S 21).
- the current value In the measuring section 14 the response current value is measured (S22), and based on the response current value, the end 3la 'of the working electrode 31' and the first extension 32Aa of the counter electrode 32 'are determined. It is determined whether there is a liquid junction between the blood and the liquid (S23). This determination is made by monitoring the response current value measured by the current value measurement unit 12 in the detection unit 15 and determining whether the response current value is greater than a predetermined threshold value or force.
- the detecting unit 15 determines that a liquid junction has occurred between the end 3 la 'of the working electrode 31' and the first extension 32Aa of the counter electrode 32 'when the response current value is larger than the threshold value. (S23: YES), otherwise, it is determined that no liquid junction has occurred (S23: NO).
- the response current measurement in S22 and the measurement of S23 are performed until the liquid junction is detected by the detecting unit 15 (S23: YES). Repeat the decision.
- the measurement of the response current value in S22 is performed, for example, every 0.05 to 0.2 sec. However, if the determination in S23 is completed a predetermined number of times, or if a liquid junction is not detected after a certain period of time (S23: NO), error processing may be performed.
- the detection unit 15 determines that the introduction of blood into the interior of the capillary 6 'has started, and the working electrode 3 ⁇ It is determined whether the force between the end 31a 'of the' and the second extension 32Ab of the counter electrode 32 'is a liquid junction by blood (S24). By S24, it is determined whether or not the amount of blood required for measurement has been supplied into the inside of the capillary 6 '.
- the liquid junction detection process in S24 is performed according to, for example, the flowchart shown in FIG.
- the response current value A is obtained by the first measurement at the current value measurement unit 14 at which the response current value is measured at regular intervals (S31). Then, the response current value B is obtained by the next sampling (S32). Next, the response current value A is subtracted from the response current value B to calculate the increase ⁇ (S33). Next, by the next sampling, a response current value C is obtained (S34), and the response current value is obtained. The previous response current value ⁇ is subtracted from the flow value C to calculate the increment i3 (S35).
- the detection unit 15 detects the blood between the end 31a 'of the working electrode 31' and the second extension 32Ab of the counter electrode 32 'by blood. It is determined that a liquid junction has occurred (S37).
- the detecting unit 15 determines that no liquid junction has occurred, and determines the current measurement current value C Is set as the current value B (S38), the current increase amount] 3 is set as the previous increase amount ⁇ (S39), and the next measured current value is obtained, and the procedure from S31 to S36 is repeated.
- the oxidation-reduction reaction proceeds in the liquid-phase reaction system built inside the capillary 6 ′, and in the biosensor 2 ′, the surface area of the second extension portion 32 Ab is larger than the area of the first extension portion 32 Aa. Has also been enlarged. Therefore, when blood reaches the surface of the second extension 32 Ab, a large change may occur in the measured response current value. Therefore, in the liquid junction detection process in S24, the end 3la 'of the working electrode 31' and the second extension 32 Ab of the counter electrode 32 'are easily and reliably based on the rapid change in the response current value. It is possible to detect that a liquid junction has occurred between the two.
- the detecting section 15 acquires a response current value when a liquid junction is detected in S24 (S37). This response current correction is stored in the storage unit 11, for example.
- the detecting unit 15 further determines whether the force has passed for a predetermined time since the liquid junction was detected in S24 (S37) (S26). This determination is repeated until the detection unit 15 determines that the predetermined time has elapsed (S26: YES).
- the current value measurement unit 14 measures a response current value for calculation (S27).
- a specific time after the liquid junction is detected in S24 (S37).
- the response current value is measured for each time, and the response current value after a certain time has passed since the liquid junction detection in S24 (S37) is sampled, and the sampled response current value is adopted as the response current value for calculation.
- acquisition of the response current value in S27 may be performed in S23 after a lapse of a fixed time from the detection of the liquid junction.
- the calculating unit 16 calculates the blood sugar level (S28).
- the calculation of the blood glucose level is performed, for example, by calculating the difference between the response current value for calculation measured in S27 and the response current value measured in S25, and calculating the difference and the detection value stored in the storage unit 11. It is performed by The calculation result of the blood sugar level is displayed on the display unit 17 (S29).
- a threshold value set in advance and a measured response current value are compared to determine the power at which a sufficient amount of blood has been supplied to the capillary for measurement.
- the liquid junction between the end 3 la ′ of the working electrode 3 1 ′ and the second extension 32 ab of the counter electrode 3 2 ′ increases the response current value.
- the detection is performed based on the amount (S36).
- the liquid junction is detected by a relative comparison between the measured response current values. You. Therefore, even if the magnitude of the hematocrit value affects the measured response current value, it is possible to detect a liquid junction without being affected by the response current value. Therefore, it is possible to reliably detect whether or not the force required to supply the amount of blood required for measurement to the cabins 6 '.
- the calculation of the blood sugar level in S28 is performed based on the difference between the response current value measured in S27 and the response current value measured in S25. Since this difference is also a relative comparison amount, it is possible to perform the density calculation excluding the influence of the magnitude of the hematocrit value, and to perform more appropriate density measurement. In this embodiment, correction similar to that in the first embodiment described above may be performed.
- S 2 4 (S 3 7) Calculate the time required to detect a liquid junction between the end 3 1 a ′ of the working electrode 3 1 ′ and the second extension 32 ab of the counter electrode 3 2 ′.
- the correction may be performed based on the required time.
- the present invention is not limited to the examples described in the first and second embodiments.
- the present invention can be applied to, for example, a substance other than blood as a sample liquid, for example, urine, and a substance to be measured other than gnorecose, for example, cholesterol.
- the present invention can be applied not only to the hematocrit value but also to the concentration measurement in consideration of other factors affecting the response current value, for example, the degree of chyle or the degree of hemolysis of the sample solution.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/492,432 US7491310B2 (en) | 2001-10-12 | 2002-10-09 | Concentration measuring method and concentration measuring apparatus |
EP02775306.0A EP1443322B1 (en) | 2001-10-12 | 2002-10-09 | Concentration measuring method and concentration measuring device |
JP2003536740A JP4246633B2 (ja) | 2001-10-12 | 2002-10-09 | 濃度測定方法および濃度測定装置 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-315552 | 2001-10-12 | ||
JP2001315553 | 2001-10-12 | ||
JP2001-315553 | 2001-10-12 | ||
JP2001315552 | 2001-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003034055A1 true WO2003034055A1 (fr) | 2003-04-24 |
Family
ID=26623876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/010505 WO2003034055A1 (fr) | 2001-10-12 | 2002-10-09 | Procede de mesure de concentration et dispositif de mesure de concentration |
Country Status (5)
Country | Link |
---|---|
US (1) | US7491310B2 (ja) |
EP (1) | EP1443322B1 (ja) |
JP (1) | JP4246633B2 (ja) |
CN (1) | CN100367030C (ja) |
WO (1) | WO2003034055A1 (ja) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005103669A1 (ja) * | 2004-04-19 | 2005-11-03 | Matsushita Electric Industrial Co., Ltd. | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
EP1707953A1 (en) * | 2003-12-04 | 2006-10-04 | Matsushita Electric Industrial Co., Ltd. | HEMATOCRIT (Htc) MEASURING METHOD, SENSOR USED FOR SAME, AND MEASURING INSTRUMENT |
JP2007024898A (ja) * | 2005-07-19 | 2007-02-01 | Hypoguard Ltd | バイオセンサとその製造方法 |
JP2007114197A (ja) * | 2005-10-17 | 2007-05-10 | Lifescan Inc | 生理液の測定方法 |
JPWO2005054840A1 (ja) * | 2003-12-04 | 2007-06-28 | 松下電器産業株式会社 | 血液成分の測定方法およびそれに用いるセンサならびに測定装置 |
JP2007303968A (ja) * | 2006-05-11 | 2007-11-22 | Arkray Inc | 血液試料中の特定成分の濃度測定方法および装置 |
JP2009229469A (ja) * | 2009-06-01 | 2009-10-08 | Arkray Inc | 分析用具およびその製造方法 |
US7897033B2 (en) * | 2005-08-08 | 2011-03-01 | Infopia Co., Ltd. | Method and apparatus for measuring sample reaction results on biosensor |
JP2011137816A (ja) * | 2009-12-30 | 2011-07-14 | Lifescan Inc | 初期充填速度に基づく全血ヘマトクリット値を測定するためのシステム、デバイス、及び方法 |
JP2016186501A (ja) * | 2004-05-14 | 2016-10-27 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 生物学的分析物を分析検査するボルタンメトリーシステム |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
CN100346158C (zh) * | 2000-11-30 | 2007-10-31 | 松下电器产业株式会社 | 基质的定量方法 |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
JP4149911B2 (ja) | 2001-06-12 | 2008-09-17 | ペリカン テクノロジーズ インコーポレイテッド | 電気式ランセットアクチュエータ |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
DE60239132D1 (de) | 2001-06-12 | 2011-03-24 | Pelikan Technologies Inc | Gerät zur erhöhung der erfolgsrate im hinblick auf die durch einen fingerstich erhaltene blutausbeute |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
AU2002315177A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
EP1628567B1 (en) | 2003-05-30 | 2010-08-04 | Pelikan Technologies Inc. | Method and apparatus for fluid injection |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR PROVIDING IMPROVED SAMPLE CAPTURING DEVICE |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
WO2005065414A2 (en) | 2003-12-31 | 2005-07-21 | Pelikan Technologies, Inc. | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
ES2535657T3 (es) * | 2005-09-14 | 2015-05-13 | Sumitomo Electric Industries, Ltd. | Dispositivo de medición por biosensor, sistema de medición por biosensor, y método de medición por biosensor |
US7429865B2 (en) | 2005-10-05 | 2008-09-30 | Roche Diagnostics Operations, Inc. | Method and system for error checking an electrochemical sensor |
WO2007131036A1 (en) * | 2006-05-03 | 2007-11-15 | Bayer Healthcare Llc | Underfill detection system for an electrochemical biosensor |
US8080153B2 (en) * | 2007-05-31 | 2011-12-20 | Abbott Diabetes Care Inc. | Analyte determination methods and devices |
EP2193367B1 (en) * | 2007-09-27 | 2019-01-23 | Philosys CO., LTD. | Method for correcting erroneous results of measurement in biosensors and apparatus using the same |
JP4811380B2 (ja) * | 2007-09-28 | 2011-11-09 | パナソニック株式会社 | バイオセンサを用いた測定方法 |
WO2009125930A1 (en) * | 2008-04-08 | 2009-10-15 | All Medicus Co.,Ltd. | Bio-sensor |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
TWI388823B (zh) * | 2009-04-09 | 2013-03-11 | Bionime Corp | 一種判斷樣品佈滿狀況的偵測方法 |
CN106053585A (zh) * | 2009-05-12 | 2016-10-26 | 华广生技股份有限公司 | 一种判断样品布满状况的侦测方法 |
IN2012DN02872A (ja) | 2009-11-10 | 2015-07-24 | Bayer Healthcare Llc | |
US8101065B2 (en) | 2009-12-30 | 2012-01-24 | Lifescan, Inc. | Systems, devices, and methods for improving accuracy of biosensors using fill time |
KR101929057B1 (ko) * | 2010-03-22 | 2018-12-13 | 바이엘 헬쓰케어 엘엘씨 | 바이오센서를 위한 잔여 보상 |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
JP5856154B2 (ja) | 2010-06-07 | 2016-02-09 | バイエル・ヘルスケア・エルエルシーBayer HealthCareLLC | 二次出力シグナルを含む勾配に基づく補正 |
CN103038636B (zh) | 2010-06-07 | 2015-01-14 | 拜尔健康护理有限责任公司 | 用于生物传感器的未充满管理*** |
US9482636B2 (en) * | 2010-10-28 | 2016-11-01 | Panasonic Healthcare Holdings Co., Ltd. | Vital information measurement device and vital information measurement method employing same |
MX350696B (es) | 2011-09-21 | 2017-09-14 | Ascensia Diabetes Care Holdings Ag | Biosensor con compensación de error. |
CN104407028B (zh) * | 2014-11-27 | 2017-01-11 | 三诺生物传感股份有限公司 | 一种试条电极的控制方法和*** |
US11199551B1 (en) | 2017-11-22 | 2021-12-14 | Jim Connolly | Test sensors, systems, and analysis techniques for measuring glycated hemoglobin in undiluted blood samples |
US11067529B2 (en) | 2017-11-22 | 2021-07-20 | Jim Connolly | Multi-zone, fixed potential test sensor heating system |
US12019045B2 (en) | 2018-10-11 | 2024-06-25 | MX3 Diagnostics, Inc. | Ion selective sensor |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06109688A (ja) * | 1992-09-25 | 1994-04-22 | Matsushita Electric Ind Co Ltd | 液体の成分測定装置 |
EP0732406A1 (en) * | 1995-03-17 | 1996-09-18 | Matsushita Electric Industrial Co., Ltd. | A method and a device for quantifying a substrate in a sample liquid using a biosensor |
EP1074832A1 (en) * | 1999-08-02 | 2001-02-07 | Bayer Corporation | Improved electrochemical-sensor design |
JP2001330581A (ja) * | 2000-05-19 | 2001-11-30 | Matsushita Electric Ind Co Ltd | 基質濃度定量法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5320732A (en) * | 1990-07-20 | 1994-06-14 | Matsushita Electric Industrial Co., Ltd. | Biosensor and measuring apparatus using the same |
JP3135959B2 (ja) * | 1991-12-12 | 2001-02-19 | アークレイ株式会社 | バイオセンサーおよびそれを用いた分離定量方法 |
JPH0810208A (ja) | 1994-06-30 | 1996-01-16 | Toshiba Corp | 食器洗浄機 |
US5650062A (en) * | 1995-03-17 | 1997-07-22 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
US5628890A (en) * | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
JP3848993B2 (ja) | 1998-01-06 | 2006-11-22 | アークレイ株式会社 | 共存物質の存在下における成分量の測定方法及び測定装置 |
US7312087B2 (en) * | 2000-01-11 | 2007-12-25 | Clinical Micro Sensors, Inc. | Devices and methods for biochip multiplexing |
-
2002
- 2002-10-09 CN CNB028201507A patent/CN100367030C/zh not_active Expired - Lifetime
- 2002-10-09 JP JP2003536740A patent/JP4246633B2/ja not_active Expired - Lifetime
- 2002-10-09 EP EP02775306.0A patent/EP1443322B1/en not_active Expired - Lifetime
- 2002-10-09 US US10/492,432 patent/US7491310B2/en active Active
- 2002-10-09 WO PCT/JP2002/010505 patent/WO2003034055A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06109688A (ja) * | 1992-09-25 | 1994-04-22 | Matsushita Electric Ind Co Ltd | 液体の成分測定装置 |
EP0732406A1 (en) * | 1995-03-17 | 1996-09-18 | Matsushita Electric Industrial Co., Ltd. | A method and a device for quantifying a substrate in a sample liquid using a biosensor |
EP1074832A1 (en) * | 1999-08-02 | 2001-02-07 | Bayer Corporation | Improved electrochemical-sensor design |
JP2001330581A (ja) * | 2000-05-19 | 2001-11-30 | Matsushita Electric Ind Co Ltd | 基質濃度定量法 |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4717636B2 (ja) * | 2003-12-04 | 2011-07-06 | パナソニック株式会社 | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
EP1707953A1 (en) * | 2003-12-04 | 2006-10-04 | Matsushita Electric Industrial Co., Ltd. | HEMATOCRIT (Htc) MEASURING METHOD, SENSOR USED FOR SAME, AND MEASURING INSTRUMENT |
US9719956B2 (en) | 2003-12-04 | 2017-08-01 | Panasonic Healthcare Holdings Co., Ltd. | Method of measuring blood component, sensor used in the method, and measuring device |
US9213012B2 (en) | 2003-12-04 | 2015-12-15 | Panasonic Healthcare Holdings Co., Ltd. | Method of measuring blood component, sensor used in the method, and measuring device |
JPWO2005054839A1 (ja) * | 2003-12-04 | 2007-06-28 | 松下電器産業株式会社 | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
JPWO2005054840A1 (ja) * | 2003-12-04 | 2007-06-28 | 松下電器産業株式会社 | 血液成分の測定方法およびそれに用いるセンサならびに測定装置 |
US8540864B2 (en) | 2003-12-04 | 2013-09-24 | Panasonic Corporation | Method of measuring blood component, sensor used in the method, and measuring device |
US8535497B2 (en) | 2003-12-04 | 2013-09-17 | Panasonic Corporation | Method of measuring blood component, sensor used in the method, and measuring device |
EP1707953A4 (en) * | 2003-12-04 | 2009-12-23 | Panasonic Corp | HEMATOCRIT (HTC) MEASURING PROCEDURE, SENSOR AND MEASURING DEVICE USED THEREFOR |
US8480869B2 (en) | 2003-12-04 | 2013-07-09 | Panasonic Corporation | Method of measuring hematocrit (Hct), sensor used in the method, and measuring device |
US8088271B2 (en) | 2003-12-04 | 2012-01-03 | Panasonic Corporation | Method of measuring hematocrit (Hct), sensor used in the method, and measuring device |
JP2011141302A (ja) * | 2003-12-04 | 2011-07-21 | Panasonic Corp | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
JP2011047964A (ja) * | 2003-12-04 | 2011-03-10 | Panasonic Corp | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
JP2011047962A (ja) * | 2003-12-04 | 2011-03-10 | Panasonic Corp | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
JP2011047963A (ja) * | 2003-12-04 | 2011-03-10 | Panasonic Corp | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
JP2011141301A (ja) * | 2003-12-04 | 2011-07-21 | Panasonic Corp | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
JP2011141300A (ja) * | 2003-12-04 | 2011-07-21 | Panasonic Corp | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
JP2011033638A (ja) * | 2004-04-19 | 2011-02-17 | Panasonic Corp | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
JP2011033637A (ja) * | 2004-04-19 | 2011-02-17 | Panasonic Corp | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
US7955492B2 (en) | 2004-04-19 | 2011-06-07 | Panasonic Corporation | Method for measuring blood components and biosensor and measuring instrument for use therein |
US9285335B2 (en) | 2004-04-19 | 2016-03-15 | Panasonic Healthcare Holdings Co., Ltd. | Method for measuring blood components and biosensor and measuring instrument for use therein |
JP4689601B2 (ja) * | 2004-04-19 | 2011-05-25 | パナソニック株式会社 | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
US8524055B2 (en) | 2004-04-19 | 2013-09-03 | Panasonic Corporation | Method for measuring blood components and biosensor and measuring instrument for use therein |
JP4696183B2 (ja) * | 2004-04-19 | 2011-06-08 | パナソニック株式会社 | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
JP4751479B2 (ja) * | 2004-04-19 | 2011-08-17 | パナソニック株式会社 | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
WO2005103669A1 (ja) * | 2004-04-19 | 2005-11-03 | Matsushita Electric Industrial Co., Ltd. | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
KR101108381B1 (ko) | 2004-04-19 | 2012-01-30 | 파나소닉 주식회사 | 혈액 성분의 측정 방법, 그것에 이용하는 바이오 센서 및측정 장치 |
JP2016186501A (ja) * | 2004-05-14 | 2016-10-27 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 生物学的分析物を分析検査するボルタンメトリーシステム |
JP2007024898A (ja) * | 2005-07-19 | 2007-02-01 | Hypoguard Ltd | バイオセンサとその製造方法 |
US7897033B2 (en) * | 2005-08-08 | 2011-03-01 | Infopia Co., Ltd. | Method and apparatus for measuring sample reaction results on biosensor |
US20120043201A1 (en) * | 2005-08-08 | 2012-02-23 | Infopia Co., Ltd. | Method and apparatus for measuring sample reaction results on biosensor |
US8702923B2 (en) | 2005-08-08 | 2014-04-22 | Infopia Co., Ltd. | Method and apparatus for measuring sample reaction results on biosensor |
JP2007114197A (ja) * | 2005-10-17 | 2007-05-10 | Lifescan Inc | 生理液の測定方法 |
US8486245B2 (en) | 2005-10-17 | 2013-07-16 | Lifescan, Inc. | Methods for measuring physiological fluids |
JP2007303968A (ja) * | 2006-05-11 | 2007-11-22 | Arkray Inc | 血液試料中の特定成分の濃度測定方法および装置 |
JP4674283B2 (ja) * | 2009-06-01 | 2011-04-20 | アークレイ株式会社 | 分析用具およびその製造方法 |
JP2009229469A (ja) * | 2009-06-01 | 2009-10-08 | Arkray Inc | 分析用具およびその製造方法 |
KR101316559B1 (ko) * | 2009-12-30 | 2013-10-15 | 라이프스캔, 인코포레이티드 | 초기 충전 속도에 기초하여 전혈 헤마토크릿을 측정하기 위한 시스템, 장치, 및 방법 |
US8877034B2 (en) | 2009-12-30 | 2014-11-04 | Lifescan, Inc. | Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity |
JP2011137816A (ja) * | 2009-12-30 | 2011-07-14 | Lifescan Inc | 初期充填速度に基づく全血ヘマトクリット値を測定するためのシステム、デバイス、及び方法 |
JP2013050466A (ja) * | 2009-12-30 | 2013-03-14 | Lifescan Inc | 初期充填速度に基づく全血ヘマトクリット値を測定するための方法 |
JP2012194196A (ja) * | 2009-12-30 | 2012-10-11 | Lifescan Inc | サンプル中の分析物の濃度を決定するためのシステム、デバイス、及び方法 |
US9927388B2 (en) | 2009-12-30 | 2018-03-27 | Lifescan, Inc. | Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity |
Also Published As
Publication number | Publication date |
---|---|
CN1633596A (zh) | 2005-06-29 |
EP1443322B1 (en) | 2013-07-17 |
US7491310B2 (en) | 2009-02-17 |
JPWO2003034055A1 (ja) | 2005-02-03 |
JP4246633B2 (ja) | 2009-04-02 |
US20040232009A1 (en) | 2004-11-25 |
CN100367030C (zh) | 2008-02-06 |
EP1443322A1 (en) | 2004-08-04 |
EP1443322A4 (en) | 2005-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003034055A1 (fr) | Procede de mesure de concentration et dispositif de mesure de concentration | |
EP2149792B1 (en) | Sample analyzing method | |
EP1411348B1 (en) | Implement and device for analysis | |
RU2571285C2 (ru) | Определение электрической емкости при электрохимическом анализе с улучшенным смещением времени выборки | |
RU2647473C2 (ru) | Системы и способы для улучшенной стабильности электрохимических сенсеров | |
EP2539711B1 (en) | Capacitance detection in electrochemical assay | |
JP4862195B2 (ja) | バイオセンサ測定機、バイオセンサ測定システム及びバイオセンサ測定方法 | |
KR200435115Y1 (ko) | 빠른 시료주입이 가능한 바이오센서 | |
US20170276632A1 (en) | Method and device for determining volumetric sufficiency in an electrochemical test strip | |
JP5073629B2 (ja) | バイオセンサが取り付けられる計測表示装置および測定方法 | |
WO2021015759A1 (en) | Method for determining analyte concentration in a sample | |
AU2015221473A1 (en) | Capacitance detection in electrochemical assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003536740 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10492432 Country of ref document: US Ref document number: 20028201507 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002775306 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002775306 Country of ref document: EP |